Recombinant DNA (rDNA) refers to artificial DNA molecules that are created by combining genetic material from different sources. This technology involves the insertion of DNA fragments from one ...
Our animal-origin free recombinant proteins and enzymes portfolio, developed with Dyadic, augments Fermbox’s strategy ...
The AI2Health cluster of the Ken Kennedy Institute and the Synthetic Biology Institute at Rice University hosted a debriefing and collaborative discussion session on the Spirit of Asilomar summit June ...
The global biotechnology market is expected to grow at a rate of 13-15% over the next five years. Key drivers of this growth ...
Without Drs. Herbert Boyer and Stan Cohen, the biotechnology industry would probably not exist, or at least appear in the form that we currently know it. And, of course, there would be no GEN. However ...
Errol Friedberg is a molecular biologist and emeritus professor at University of Texas Southwestern Medical Center in Dallas. He is author of A Biography of Paul Berg: The Recombinant DNA Controversy ...
The first peer-reviewed journal in the field of human gene therapy, providing all-inclusive coverage of the research, methods, and clinical developments that are driving today's explosion of gene ...
Dyadic Applied BioSolutions (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company producing precision-engineered, animal-free proteins and enzymes for life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results